Browsing Tag
D-0316
1 post
InventisBio licenses lung cancer drug D-0316 to Betta Pharma in RMB230m deal
In a significant development within the pharmaceutical industry, Shanghai-based InventisBio has entered into a strategic partnership with Betta…